|  | 
  
    
    
      | 
          CXCL11-Fc         |  
      | Vaxjo ID | 298 |  
      | Vaccine Adjuvant Name | CXCL11-Fc |  
      | Adjuvant VO ID | VO_0005590 |  
      | Description | fusion protein adjuvant derived from fc fused CXCL11 that induces Th1 response |  
      | Stage of Development | Research |  
      | Host Species for Testing | Mouse |  
      | Preparation | subcloned into the adenoviral shuttle vector |  
      | Function | increase antigen-specific CD8 T cell immunity |  
	  | References | Namkoong et al., 2014: Namkoong H, Song MY, Seo YB, Choi DH, Kim SW, Im SJ, Sung YC, Park Y. Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11. Vaccine. 2014; 32(10); 1205-1212. [PubMed: 23928465]. |  |